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  The  present  experiments  were  done  to  determine  the 
effectiveness of a non-specific nitric oxide synthase inhibitor, 
N-nitro-L-arginine methyl ester (L-NAME), on oxidative 
stress parameters induced by aluminium chloride (AlCl3) 
intrahippocampal injections in Wistar rats. Animals were 
sacrificed  3  h  and  30  d  after  treatments,  heads  were 
immediately frozen in liquid nitrogen and forebrain cortices 
were removed. Crude mitochondrial fraction preparations 
of forebrain cortices were used for the biochemical analyses: 
nitrite  levels,  superoxide  production,  malondialdehyde 
concentrations, superoxide dismutase (SOD) activities and 
reduced glutathione contents. AlCl3 injection resulted in 
increased nitrite concentrations, superoxide anion production, 
malondialdehyde concentrations and reduced glutathione 
contents  in  the  forebrain  cortex,  suggesting  that  AlCl3 
exposure promoted oxidative stress in this brain structure. 
The biochemical changes observed in neuronal tissues showed 
that aluminium acted as a pro-oxidant. However, the non- 
specific nitric oxide synthase (NOS) inhibitor, L-NAME, 
exerted anti-oxidant actions in AlCl3-treated animals. These 
results  revealed  that  NO-mediated  neurotoxicity  due  to 
intrahippocampal AlCl3 injection spread temporally and 
spatially to the forebrain cortex, and suggested a potentially 
neuroprotective effect for L-NAME.
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Introduction 
Neurodegenerative changes are morphologically 
characterized by progressive cell loss in vulnerable neuronal 
populations of the central nervous system (CNS), including 
specific regions of the hippocampus and specific subcortical 
regions. These changes are often associated with cytoskeletal 
protein aggregates that form intracytoplasmic and/or 
intranuclear inclusions in neurons and/or glial cells [14,27].
Aluminium (Al) is a neurotoxic metal that may be involved 
in the progression of neurodegenerative processes [9]. Entry 
of Al into the brain from the blood may involve transferrin- 
receptor mediated endocytosis and more rapid transport 
processing forsmall molecular weight Al species. There 
appears to be Al efflux from the brain, probably as Al citrate 
[43]. Several research groups have observed numerous 
ghost-like neurons with cytoplasmic and nuclear vacuolations 
and with Al deposits [21,28]. The hippocampus contained 
extracellular accumulations of Al and amyloids surrounded 
by nuclei of degenerating cells (neuritic plaques). Al 
promotes the formation and accumulation of insoluble beta 
amyloid (Abeta) and hyper-phosphorylated tau. In addition, Al 
mimics the deficient cortical cholinergic neurotransmission 
seen in several neurodegenerative diseases [43]. 
Reactive glial cell properties could contribute to the 
pathological mechanisms underlying neurodegenerative 
disturbances by favoring oxidative neuronal damage and 
Abeta toxicity [31]. Under conditions of neurodegeneration, 
excessive activation of microglia can contribute to the 
neurodegenerative process by releasing potentially cytotoxic 
substances, including the cytotoxic free radical nitric oxide 
(∙NO) [17]. Chronic exposure to Al impairs glutamate- 
induced activation of nitric oxide synthase (NOS) and 
NO-induced activation of guanylate cyclase [8]. Cortical 
nitroxidergic neurons and granule cells are specific targets 
of Al neurotoxicity [29].
The NO-synthesizing enzyme NOS is present in the 
mammalian brain in 3 different isoforms: 2 constitutive 
enzymes (neuronal nNOS and endothelial eNOS) and 1 
inducible enzyme (iNOS). All 3 isoforms are aberrantly 
expressed during Al intoxication. This gives rise to 16    Ivana D. Stevanović et al.
elevated levels of NO that are apparently involved in 
neurodegeneration by different mechanisms, including 
oxidative stress and activation of intracellular signaling 
mechanisms [19]. 
Al affects NO production in the brain. Al decreases 
glutamine synthase activity and also increases extracellular 
glutamate, which leads to developing the excitotoxic process 
that is under the influence of NO. Extracellular glutamate 
increases the influx of Ca, NOS activity and, consequently, 
increased NO synthesis [5].
Molecular oxygen (O2) is the primary biological electron 
acceptor that plays vital roles in fundamental cellular functions. 
However, concomitant with the beneficial properties of O2 
comes the inadvertent formation of reactive oxygen species 
(ROS), such as superoxide anion radical (∙O2
-), hydrogen 
peroxide (H2O2) and hydroxyl radical (∙HO) [30]. 
Accumulating evidence shows that iron (Fe) accumulates in 
the brain and catalyzes ∙O2
- formation, which reacts with 
NO to form the very toxic peroxynitrite anion (ONOO
-) [20]. 
Free radicals (oxidative toxins) have been implicated in the 
destruction of cells via lipid peroxidative damage to cell 
membranes. After exposure to Al, increased malondialdehyde 
(MDA), an index of lipid peroxidation, was observed [35].
In normal cells, oxygen derivatives are neutralized or 
eliminated by a natural defense mechanism that involves 
enzymatic anti-oxidants (glutathione peroxidase, superoxide 
dismutase, catalase) and water or fat-soluble non-enzymatic 
anti-oxidants (vitamins C and E, glutathione, selenium) [32]. 
The antioxidant thiol L-gamma-Glutamyl-L-cysteinyl- 
glycine, or glutathione (GSH), has shaped, and is still refining, 
the nature of oxidative signaling in terms of regulating the 
milieu of inflammatory mediators, ostensibly via the 
modulation of oxygen- and redox-responsive transcription 
factors. Hence, they are termed redox(y)-sensitive cofactors 
[12]. Also, anti-oxidative defense includes both of the 
superoxide dismutase (SOD)-isoforms (Mn-SOD, Cu/Zn- 
SOD), which are induced to prevent oxidative and NO/ 
ONOO
- -mediated damage [25]. 
Cell death and changes in neurite morphology were partly 
reduced when the NO concentration was inhibited by NOS 
inhibitors [23]. Our previous results indicated positive 
effects of pre-treatment with NOS inhibitors on the 
development of neurotoxicity [33,38]. In view of the above 
considerations, the present study was undertaken to examine 
if the nitrite levels, ∙O2
- production, MDA concentrations, 
SOD activities and GSH contents that result after 
intracerebral injections of aluminium chloride (AlCl3) could 
be modulated by pretreatment with N-nitro-L-arginine 
methyl ester (L-NAME), a non-specific NOS inhibitor.
Materials and Methods
Animals
Male adult Wistar rats (500 ± 50 g) were used for these 
experiments. Animals were housed 2 or 3 per cage (Erath, 
Germany) in an air-conditioned room at a temperature of 
23 ± 2
oC, 55 ± 10% humidity and with lights on 12 h/d 
(07:00-19:00). The animals were given a commercial rat 
diet and tap water ad libitum. Animals used for these 
procedures were treated in strict accordance with the NIH 
Guide for Care and Use of Laboratory Animals (USA).
Chemicals
All chemicals were of analytical grade or better. AlCl3 was 
purchased from Sigma (USA); L-NAME was purchased 
from Sigma (USA); saline solution (0.9% w/v) was provided 
by the Hospital Pharmacy (Military Medical Academy, 
Serbia). All drug solutions were prepared on the day of the 
experiments. 
Experimental procedures
The rats were anesthetized by intraperitoneal injection of 
pentobarbital sodium (45 mg/kg b.w.) before 
intrahippocampal administration of the following: (1) 
control group (n = 8) treated with 10 μl of 0.9% saline 
solution; (2) AlCl3 group (n = 15) - animals were treated 
with AlCl3 with 1 single dose (3.7 × 10
-4 g/kg b.w. in 0.01 
ml of deionizied water); (3) L-NAME + AlCl3 group (n = 
10) - animals were pre-treated with L-NAME with 1 single 
dose (1 × 10
-4 g dissolved in saline) before AlCl3 
administration; (4) L-NAME group (n = 10) - animals were 
treated with L-NAME with 1 single dose (1 × 10
-4 g dissolved 
in saline) before saline administration.
Using a stereotaxic instrument for small animals, chemicals 
were injected by Hamilton microsyringe into the CA1 
sector of the hippocampus (coordinates: 2.5 A; 4.2 L; 2.4 
V) [16]. L-NAME was immediately injected before the 
neurotoxin/saline solution. For all treated animals, the 
injected intracerebral volume was 10 μl and was always 
injected into the left side. 
The 4 experimental groups groups (based on drug treatment) 
were subdivided into 2 subgroups each. At 2 time points 
after the treatments, 3 h and 30 d, animals in the subgroups 
were decapitated. Heads were immediately frozen in liquid 
nitrogen and stored at -70
oC until use. Crude mitochondrial 
fraction preparations of forebrain cotices were used for the 
biochemical analyses [11].
Biochemical analyses 
After deproteinization, the production of NO was evaluated 
by measuring nitrite and nitrate concentrations. Nitrites were 
assayed directly by spectrophotometry at 492 nm using the 
colorimetric method of Griess (Griess reagent: 1.5% 
sulfanilamide in 1 M HCl plus 0.15% N-(1-naphthyl) 
ethylendiamine dihydrochloride in distilled water). Nitrates 
were first transformed into nitrites by cadmium reduction [24]. 
Superoxide anion (∙O2
-) content was determined by the 
reduction of nitroblue-tetrazolium (Merck, Germany) in The effect of L-NAME on AlCl3 toxicity in the rat brain    17
Fig. 1. The effects of intrahippocampal drug injection on nitrite 
levels (nM nitrite/mg protein) in the rat ipsilateral and 
contralateral forebrain cortex at different survival times: 3 h (A)
and 30 d (B). Results are means ± SD of 10 animals. *Indicates a 
statistically significant difference between treated (AlCl3-, 
L-NAME + AlCl3- and L-NAME-treated) and control (sham- 
operated) animals (p ＜ 0.05). ∙Indicates a statistically significant
difference between treated (L-NAME + AlCl3- and L-NAME- 
treated) and AlCl3-treated animals (p  ＜ 0.05). 
򰇮Indicates a 
statistically significant difference between L-NAME-treated and
L-NAME + AlCl3-treated animals (p ＜ 0.05).
the alkaline nitrogen saturated medium. Kinetic analysis 
was performed at 550 nm [2]. 
A lipid peroxidation index was determined as the quantity 
of malondialdehide (MDA) produced. Thiobarbituric acid 
(TBA) reagent (15% trichloroacetic acid + 0.375% TBA + 
0.25% mol HCl) reacted with MDA, which was derived from 
polysaturated fatty acids during peroxidation. The reaction 
product, MDA, was measured spectrophotometrically at 
533 nm [39].
SOD activity was measured spectrophotometrically as an 
inhibition of epinephrine spontaneous auto-oxidation at 480 
nm. The kinetics of sample enzyme activity was followed 
in a carbonate buffer (50 mM, pH 10.2; Serva Feinbiochemica, 
Germany), which contained 0.1 mM EDTA (Sigma, USA), 
after the addition of 10 mM epinephrine (Sigma, USA) [34].
Content of reduced GSH was determined using 5,5- 
dithiobis-2-nitrobenzoic acid (DTNB, 36.9 mg in 10 ml of 
methanol), which had reacted with aliphatic thiol compounds 
in Tris-HCl buffer (0.4 mol, pH-8.9). This produced a yellow 
colored p-nitrophenol anion. Color intensity was used for 
spectrophotometric determination of GSH concentration 
at 412 nm. Brain tissue was prepared in 10% sulfosalicylic 
acid for GSH determination [1].
The protein content in the rat brain homogenates (forebrain 
cortex, ipsi- and contralateral) was measured by the Lowry 
method using bovine serum albumin (Sigma, USA) as a 
standard [18].
Statistical analysis
Results are given as means ± SD. Experimental group 
comparisons used either Student’s t-test or ANOVA followed 
by Tukey’s t-test. A p-value ＜ 0.05 was considered significant.
Results
Nitrite levels in the rat forebrain cortex
The results in Fig. 1 show the bilateral nitrite levels (nM/ 
mg proteins) in the rat forebrain cortex homogenates at 3 h 
(A) and 30 d (B) after the treatments. At the earlier test time, 
3 h, AlCl3 injection resulted in increased nitrite production 
in the ipsilateral forebrain cortex that was significantly 
different compared to the control group (p ＜ 0.05). Also, 
L-NAME + AlCl3 injection resulted in increased bilateral 
nitrite production in the forebrain cortex after 3 h compared 
to the control group. However, after 30 d, the L-NAME + 
AlCl3 injection resulted in lower nitrite levels compared to 
both the control and the AlCl3-treated groups (p ＜ 0.05). At 
3 h after L-NAME injection, nitrite production showed 
increased bilateral levels in the forebrain cortex compared 
to the control (p ＜ 0.05). However, after 30 d, L-NAME 
injection resulted in lower nitrite levels in both the ipsi- and 
contralateral forebrain cortices compared to both the 
controls and the AlCl3-treated animals. After 30 d, L-NAME 
injection resulted in increased nitrite production in the 
ipsilateral forebrain cortex compared to the L-NAME + 
AlCl3-treated group (Fig. 1). 
Superoxide  anion  radical  production  in  the  rat 
forebrain cortex
The results in Fig. 2 show the bilateral ∙O2
- levels (μM red 
NBT/min/mg proteins) in the rat forebrain cortex 
homogenates at 3 h (A) and 30 d (B) after the treatments. 
AlCl3 injection resulted in higher levels of ∙O2
- production 
after 3 h in the contralateral and after 30 d in both ipsi- and 
contralateral forebrain cortices compared to control animals 
(p ＜ 0.05). In the L-NAME + AlCl3 group at 3 h, ∙O2
- 
production decreased bilaterally in the forebrain cortex 
compared to the AlCl3-treated group. Also, in the L-NAME 18    Ivana D. Stevanović et al.
Fig. 2. The effects of intrahippocampal drug injection on ∙O2
-
levels (μM red. NBT/min/mg proteins) in the rat ipsilateral and 
contralateral forebrain cortex at different survival times: 3 h (A) 
and 30 d (B). Results are means ± SD of 10 animals. *Indicates a 
statistically significant difference between treated (AlCl3-, L- 
NAME + AlCl3- and L-NAME-treated) and control (sham-operated)
animals (p ＜ 0.05). ∙Indicates a statistically significant difference
between treated (L-NAME + AlCl3- and L-NAME-treated) and 
AlCl3-treated animals (p ＜ 0.05).
Fig. 3. The effects of intrahippocampal drug injection on lipide 
peroxidation (nM MDA/h/mg proteins) in the rat ipsilateral and
contralateral forebrain cortex at different survival times: 3 h (A)
and 30 d (B). Results are means ± SD of 10 animals. *Indicates a 
statistically significant difference between treated (AlCl3- and L-
NAME-treated) and control (sham-operated) animals (p ＜ 0.05).
∙Indicates a statistically significant difference between treated 
(L-NAME + AlCl3- and L-NAME-treated) and AlCl3-treated 
animals (p ＜ 0.05). 
򰇮Indicates a statistically significant difference
between L-NAME-treated and L-NAME + AlCl3-treated animals
(p ＜ 0.05).
+ AlCl3 group at 30 d, ∙O2
- production decreased bilaterally 
in the same brain structure compared to both the control 
and the AlCl3-treated groups. At 3 h after L-NAME injection, 
∙O2
- production was decreased in the ipsilateral forebrain 
cortex compared with controls, and bilaterally for this 
brain structure compared to the AlCl3-treated animals. At 
30 d, NOS inhibitor injection resulted in lower bilateral ∙
O2
-  production in the forebrain cortex compared with 
controls, while higher ∙O2
- production was measured in 
both the ipsi- and contralateral forebrain cortices compared 
to the L-NAME + AlCl3-treated group (Fig. 2). 
Malondialdehyde concentrations in the rat forebrain 
cortex
The results in Fig. 3 show the MDA concentrations (nM 
MDA/h/mg proteins) in the ipsi- and contralateral forebrain 
cortex homogenates at 3 h (A) and 30 d (B) after the 
treatments. For both test times (3 h, 30 d), AlCl3 injection 
resulted in increased bilateral MDA concentrations in the 
forebrain cortex that were significantly different compared 
to controls (p ＜ 0.05). L-NAME+AlCl3 injection resulted 
in decreased MDA concentrations bilaterally in the same 
brain structure after 3 h and 30 d compared to the AlCl3- 
treated group. After 3 h, L-NAME injection resulted in a 
higher MDA concentration in the ipsilateral forebrain cortex 
compared to the control, and bilaterally in the same brain 
structure compared to the L-NAME + AlCl3-treated group. 
In contrast, lower MDA concentrations were measured in 
both the ipsi- and contralateral forebrain cortices compared The effect of L-NAME on AlCl3 toxicity in the rat brain    19
Fig. 4. The effects of intrahippocampal drug injection on SOD 
activities (U/mg proteins) in the rat ipsilateral and contralateral 
forebrain cortex at different survival times: 3 h (A) and 30 d (B). 
Results are means ± SD of 10 animals. *Indicates a statistically 
significant difference between treated (L-NAME + AlCl3- and L-
NAME-treated) and control (sham-operated) animals (p ＜ 0.05).
∙Indicates a statistically significant difference between treated 
(L-NAME + AlCl3- and L-NAME-treated) and AlCl3-treated 
animals (p ＜ 0.05). 
򰇮Indicates a statistically significant difference
between L-NAME-treated and L-NAME + AlCl3-treated animals 
(p ＜ 0.05).
Fig. 5. The effects of intrahippocampal drug injection on reduced
glutathione concentrations (nM GSH/mg proteins) in the rat 
ipsilateral and contralateral forebrain cortex at different survival 
times: 3 h (A) and 30 d (B). Results are means ± SD of 10 animals.
*Indicates a statistically significant difference between treated 
(AlCl3-, L-NAME + AlCl3- and L-NAME-treated) and control 
(sham-operated) animals (p ＜ 0.05). ∙Indicates a statistically 
significant difference between treated (L-NAME + AlCl3- and L-
NAME-treated) and AlCl3-treated animals (p ＜ 0.05). 
򰇮Indicates
a statistically significant difference between L-NAME-treated 
and L-NAME + AlCl3-treated animals (p ＜ 0.05).
to the AlCl3-treated group. After 30 d, L-NAME injection 
resulted in lower MDA bilateral concentrations in the 
forebrain cortex compared to both the control and the 
AlCl3-treated animals (Fig. 3).
Superoxide dismutase activities in the rat forebrain 
cortex
The results in Fig. 4 show the bilateral SOD activities 
(U/mg proteins) in the forebrain cortex homogenates at 3 h 
(A) and 30 d (B) after the treatments. At 3 h and 30 d after 
AlCl3 injection, there was lower SOD activity compared to 
the control group, although this was not significantly 
different. At 3 h and 30 d after L-NAME + AlCl3 injection, 
there was lower SOD activity compared to both the 
controls and the AlCl3-treated group (p ＜ 0.05). At 3 h and 
30 d, L-NAME injection resulted in lower bilateral SOD 
activity in the forebrain cortex compared to both controls 
and the AlCl3-treated animals. However, higher SOD 
activities were measured in both the ipsi- and contralateral 
forebrain cortices compared to the L-NAME + AlCl3- 
treated group (Fig. 4). 
Reduced glutathione contents in the rat forebrain 
cortex
The results in Fig. 5 show the bilateral GSH contents (nM 
GSH/mg proteins) in the forebrain cortex homogenates at 20    Ivana D. Stevanović et al.
3 h (A) and 30 d (B) after the treatments. AlCl3 injection 
resulted in higher bilateral GSH concentrations after 3 h in 
the forebrain cortex that was significantly different compared 
to the controls (p ＜ 0.05). After 3 h, L-NAME + AlCl3 
injection resulted in lower GSH contents in both the ipsi- and 
contralateral forebrain cortices compared to the AlCl3- 
treated group. Also, at 30 d after L-NAME + AlCl3 injection, 
GSH contents were decreased in both the ipsi- and 
contralateral forebrain cortices compared to both the control 
and the AlCl3-treated animals. After 3 h, L-NAME injection 
resulted in lower bilateral GSH contents in the forebrain 
cortex compared to the AlCl3-treated group. However, after 
30 d, intrahippocampal L-NAME injection resulted in 
generally higher bilateral GSH contents in the forebrain 
cortex compared to the controls, as compared to the 
AlCl3-treated animals and as compared to the L-NAME + 
AlCl3-treated animals (Fig. 5). 
Discussion
The injection of AlCl3 into the CA1 sector of the rat 
hippocampus resulted in significant increases in nitrite 
levels, ∙O2
- production, MDA concentrations and GSH 
contents in the forebrain cortex. 
Numerous afferents from all areas of the cortex and the 
thalamus represent the most important sourcees of 
excitatory amino acids, whereas the nigrostriatal pathway 
and intrinsic circuits provide the striatum with dopamine, 
acetyl choline, GABA, NO and adenosine. Together, these 
neurotransmitter systems interact with each other and with 
voltage-dependent conductances to efficiently regulate 
synaptic transmission within this circuit [3]. 
In our study, AlCl3 injection resulted in increased nitrite 
concentrations after 3 h in the ipsilateral forebrain cortex, 
and bilateral nitrite concentrations were unchanged after 
30 d in this brain structure compared to the controls. It has 
been previously shown [36] that production and oxidation 
of NO in the brain increased in the early stages of disease, 
while it decreased with increased loss of neurons.
The literature results implicate that the reaction product 
between NO and ∙O2
-, ONOO
-, is a strong oxidizing and 
nitrating agent, which can react with all classes of 
biomolecules. In the CNS, this product can be generated by 
microglial cells that are activated by pro-inflammatory 
cytokines or Abeta and by neurons when ONOO
- directly 
contributes to the initiation of the neurodegenerative 
process [40].
In our experiments, AlCl3 injection resulted in increased 
∙O2
- production after 3 h in the contralateral forebrain 
cortex compared to controls. There are several lines of 
evidence showing that Al is associated with oxidative 
stress, possibly due to the pro-oxidant properties of Abeta 
present in senile plaques. The presence of low molecular 
weight Fe compounds can stimulate free radical production 
in the brain. Both Al and Abeta can potentate free radical 
formation by stabilizing iron in its more damaging ferrous 
(Fe
2+) form, which can promote the Fenton reaction. The 
rate at which Fe
2+ was spontaneously oxidized to Fe
3+ was 
significantly lower in the presence of Al salts [42]. In 
addition, neurotoxin injection resulted in increased ∙O2
- 
production after 30 d in the ipsi- and contralateral forebrain 
cortices compared to controls. Recent results indicate that 
microglia are CNS macrophages and are primary cellular 
components of plaques that may contribute to the oxidative 
stress associated with chronic neurodegeneration [7].
Al has been shown to alter Ca
2+ flux and homeostasis and 
to facilitate the peroxidation of membrane lipids. 
Literature results suggest that Al may facilitate increases in 
intracellular Ca
2+ and ROS, and potentially contribute to 
neurotoxicity induced by other neurotoxicants [22]. We 
have shown that at all test times (3 h, 30 d) post AlCl3 
injection, there were increased bilateral MDA concentrations 
in the forebrain cortex compared to the control animals. 
Furthermore, we have shown that AlCl3 injection resulted 
in increased bilateral GSH concentrations after 3 h in the 
forebrain cortex compared to controls. Literature results 
implicate that all detrimental effects of ONOO
- could be 
successfully attenuated by the thiol-containing anti-oxidant 
tripeptide glutathione [12]. Research shows that ONOO
- 
can oxidatively modify both membranous and cytosolic 
proteins, which alters both their physical and chemical 
properties [15]. 
It has been previously shown [37] that the interactions 
between basalocortical and intracortical NOS neurons are 
involved in the spatial and temporal regulation of cortical 
perfusion following basal forebrain activation. Aluminium 
accumulation in the brain can alter neuronal signal 
transduction pathways associated with glutamate receptors. 
Impairment of the Glu-NO-cGMP pathway in the brain 
may be responsible for some of the neurological alterations 
that are induced by Al [4]. 
Decreased bilateral nitrite concentrations in the striatum at 
30 d in the L-NAME + AlCl3 group, compared to the AlCl3- 
treated group, suggested that L-NAME suppressed nitrite 
production and decreased neuron impairment via N-methyl- 
D-aspartic acid (NMDA) receptors. Neuropharmacological 
data indicate that Abeta toxicity is mediated by an 
excitotoxic cascade involving blockade of astroglial 
glutamate uptake, sustained activation of NMDA receptors 
and an overt intracellular Ca
2+ influx. These changes are 
associated with increased NOS activity in cortical target 
areas that may directly lead to the generation of free 
radicals [13]. A sustained overproduction of NO via NOS 
expression may be responsible, at least in part, for some of 
the neurodegenerative changes caused by stress and 
support a possible neuroprotective role for NOS inhibitors 
in this context [26]. 
Decreased bilateral ∙O2
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decreased MDA concentration, as well as decreased bilateral 
SOD activity, in the forebrain cortex 3 h and 30 d after 
L-NAME + AlCl3 injection, compared to AlCl3-treated 
animals, suggested reduced enzyme substrate (∙O2
-) 
production. In the same experimental group of animals, we 
showed decreased GSH contents. Our results suggest the 
importance of GSH participation in the glutathionylation 
process as a crucial anti-oxidative defense mechanism 
against irreversible protein impairment [10]. 
Under our experimental conditions, 3 h after L-NAME 
injection, there was increased bilateral NO production in 
the forebrain cortex compared to the control group. 
Literature results suggest that the inhibition of inducible 
NOS expression by L-NAME administration prevented an 
increase in nitrogen intermediates and GABA release, but 
not in glutamate release [41]. Also, recent results indicate 
that, in some circumstances, L-NAME may contribute to 
NO donation by serving as an arginine analog [6]. In contrast, 
decreased NO concentrations, as well as decreased ∙O2
- 
production, 30 d after L-NAME injection suggests a long- 
term NO synthesis inhibition by L-NAME, in addition to 
potential L-NAME anti-oxidative effects.
Decreased bilateral SOD activities along with decreased 
GSH concentrations in the forebrain cortex post L-NAME 
injection contributed to oxidative development at the early 
time point. Thirty days post L-NAME injection showed 
improvements of an oxidative stress development parameter 
(increased GSH concentration). As a potential arginine 
analog in the specified experimental groups, L-NAME 
could overlap the toxic effects of AlCl3.
At 3 h after L-NAME injection, there was a higher MDA 
concentration in the ipsilateral forebrain cortex compared 
to controls, while a lower MDA concentration was measured 
bilaterally in the forebrain cortex at 30 d post L-NAME 
application. The analysis of MDA concentration is a crucial 
parameter of membrane lipid destruction that demonstrates 
a protective effect for L-NAME in AlCl3-treated animals in 
contrast to AlCl3- and L-NAME- effects. 
Glutamate excitotoxicity, oxidative stress and mitochondrial 
dysfunctions are common features that lead to neuronal 
death after Al intoxication. Nitric oxide alone, or in 
cooperation with ∙O2
- and ONOO
-, is emerging as a 
predominant effector of neurodegeneration [5]. 
The present results revealed that NO-mediated neurotoxicity 
resulting from intrahippocampal aluminium injection 
spread temporally and spatially in the forebrain cortex, and 
suggested a potential neuroprotective effect for L-NAME.
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